|
|
SD-OCT-guided intravitreal ranibizumab treatment in choroidal neovascularization due to myopia
| Third-party funded project |
| Project title |
SD-OCT-guided intravitreal ranibizumab treatment in
choroidal neovascularization due to myopia |
| Principal Investigator(s) |
Prünte, Christian
|
| Organisation / Research unit |
Bereich Spezialfächer (Klinik) / Ophthalmologie USB |
| Project start |
01.08.2011 |
| Probable end |
31.07.2013 |
| Status |
Completed |
| Abstract |
hausinterne Studie der Vista Klinik AG, Binningen, teilfinanziert durch Novartis Pharma Schweiz AG, Monbijoustrasse 118, 3001 Bern,
(SD-OCT-guided intravitreal ranibizumab treatment in choroidal neovascularization due to myopia).
Keine Fördergelder von Basel! |
| Financed by |
Private Sector / Industry
|
| |
|
|
MCSS v5.8 PRO. 0.637 sec, queries - 0.000 sec
©Universität Basel | Impressum
|  |
|
05/05/2024
Research Database / FORSCHUNGSDATENBANK
|
